StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
JPMorgan Downgrades Gilead Sciences (GILD) to Neutral
May 1, 2020 5:36 AM
JPMorgan analyst Cory Kasimov downgraded Gilead Sciences (NASDAQ: GILD) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Downgrades
Next Articles
Gilead Sciences (GILD) PT Raised to $97 at Jefferies
May 1, 2020 4:49 AM
SunTrust Downgrades Gilead Sciences (GILD) to Sell
May 1, 2020 4:25 AM
Gilead Sciences (GILD) PT Raised to $75 at Bernstein
May 1, 2020 4:25 AM
UPDATE: Raymond James Downgrades Gilead Sciences (GILD) to Market Perform
May 1, 2020 4:25 AM
After-Hours Stock Movers 04/30: (INT) (RMD) (FND) Higher; (WDC) (ZEN) (AMZN) (AAPL) Lower (more...)
April 30, 2020 5:59 PM
Gilead Sciences (GILD) Declares $0.68 Quarterly Dividend; 3.3% Yield
April 30, 2020 5:21 PM
Gilead to work with partners to ramp up production of potential coronavirus treatment
April 30, 2020 4:32 PM
Form 8-K GILEAD SCIENCES INC For: Apr 30
April 30, 2020 4:09 PM
Gilead Sciences (GILD) Tops Q1 EPS by 11c
April 30, 2020 4:07 PM
Gilead Sciences Announces Second Quarter 2020 Dividend
April 30, 2020 4:02 PM
Gilead Sciences Announces First Quarter 2020 Financial Results
April 30, 2020 4:01 PM
Gilead Sciences (GILD) weekly IV at 116 into EPS, outlook and pipeline outlook
April 30, 2020 3:43 PM
FDA Head Says Moving at Lightning Speed on Gilead (GILD) Virus Drug, Declines to Offer Timeline for Remdesivir Review - Bloomberg
April 30, 2020 9:19 AM
Glenmark to conduct trials in India for potential COVID-19 drug
April 30, 2020 12:35 AM
